RPRX
Price:
$52.96
Market Cap:
$22.78B
Royalty Pharma plc, headquartered in New York City and founded in 1996, operates within the United States as a key player in the biopharmaceutical industry. The company primarily focuses on the acquisition of royalties from biopharmaceutical products and actively invests in funding new developments and innovations in the sector. Its activities involve diligently identifying, evaluating, and securing royalty agreements for a wide array of biopharmaceutical therapies. Beyond acquisitions, Royalty Pharma plc fosters collaborations with various innovators. These partners include academic institutions, research hospitals, non-profit organizations, small and mid-sized biotechnology firms, and larg...[Read more]
Industry
Biotechnology
IPO Date
2020-06-16
Stock Exchange
NASDAQ
Ticker
RPRX
According to Royalty Pharma plc’s latest financial reports and current stock price. The company's current PE Ratio is 27.87. This represents a change of -18.54% compared to the average of 34.21 of the last 4 quarters.
The mean historical PE Ratio of Royalty Pharma plc over the last ten years is 57.82. The current 27.87 PE Ratio has changed 4.72% with respect to the historical average. Over the past ten years (40 quarters), RPRX's PE Ratio was at its highest in in the March 2024 quarter at 747.50. The PE Ratio was at its lowest in in the December 2020 quarter at -15.64.
Average
57.82
Median
14.94
Minimum
6.71
Maximum
395.20
Discovering the peaks and valleys of Royalty Pharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.38%
Maximum Annual PE Ratio = 395.20
Minimum Annual Increase = -97.92%
Minimum Annual PE Ratio = 6.71
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 16.58 | 24.82% |
| 2024 | 13.29 | 61.29% |
| 2023 | 8.24 | -97.92% |
| 2022 | 395.20 | 1.38% |
| 2021 | 26.74 | -31.60% |
| 2020 | 39.10 | 482.57% |
| 2019 | 6.71 | -41.33% |
| 2018 | 11.44 | -12.08% |
| 2017 | 13.01 | -72.81% |
| 2016 | 47.85 | 3.23% |
The current PE Ratio of Royalty Pharma plc (RPRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.70
5-year avg
92.01
10-year avg
57.82
Royalty Pharma plc’s PE Ratio is greater than Genmab A/S (18.89), greater than United Therapeutics Corporation (18.33), greater than Incyte Corporation (13.45), greater than Fresenius Medical Care AG & Co. KGaA (12.41), greater than Summit Therapeutics Inc. (-9.82), greater than Smith & Nephew plc (20.12), greater than Roivant Sciences Ltd. (-69.84), less than Hologic, Inc. (31.28), greater than Tenet Healthcare Corporation (8.90), greater than Exelixis, Inc. (16.64),
| Company | PE Ratio | Market cap |
|---|---|---|
| 18.89 | $15.51B | |
| 18.33 | $22.78B | |
| 13.45 | $19.62B | |
| 12.41 | $12.67B | |
| -9.82 | $10.67B | |
| 20.12 | $12.74B | |
| -69.84 | $22.61B | |
| 31.28 | $16.97B | |
| 8.90 | $14.86B | |
| 16.64 | $13.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Royalty Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Royalty Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Royalty Pharma plc's PE Ratio?
How is the PE Ratio calculated for Royalty Pharma plc (RPRX)?
What is the highest PE Ratio for Royalty Pharma plc (RPRX)?
What is the 3-year average PE Ratio for Royalty Pharma plc (RPRX)?
What is the 5-year average PE Ratio for Royalty Pharma plc (RPRX)?
How does the current PE Ratio for Royalty Pharma plc (RPRX) compare to its historical average?